315 related articles for article (PubMed ID: 5990194)
1. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
Blasi A; Licciardello M
Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
[No Abstract] [Full Text] [Related]
2. [Research on skin temperature and internal temperature in subjects with obliterating arteriopathy. Action of the association of kallikrein and meso-inositol hexanicotinate].
Blasi A; Licciardello M
Clin Ter; 1966 Oct; 39(1):33-8. PubMed ID: 5998855
[No Abstract] [Full Text] [Related]
3. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy].
D'Ayala Valva G
Recenti Prog Med; 1966 Jun; 40(6):XIX-XXXVI. PubMed ID: 6014405
[No Abstract] [Full Text] [Related]
4. [Medical therapy of obliterating arteriopathies].
Schwarz D
Minerva Med; 1969 Oct; 60(87):4335-44. PubMed ID: 4242895
[No Abstract] [Full Text] [Related]
5. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations].
Bonessa C; Cremonini L
Minerva Med; 1966 Jul; 57(44):2027-40. PubMed ID: 5942708
[No Abstract] [Full Text] [Related]
6. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
[No Abstract] [Full Text] [Related]
7. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
Cascio F
Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
[No Abstract] [Full Text] [Related]
8. [Considerations on the use of dextran of low molecular weight in the treatment of peripheral arteriopathy].
Serra GC; Verlato R
Acta Anaesthesiol; 1965; 16():Suppl 5:87-95. PubMed ID: 5899665
[No Abstract] [Full Text] [Related]
9. [Effect of bencyclane in obliterative arterial diseases].
Kusztos D
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
[No Abstract] [Full Text] [Related]
10. [Research on the activity of propaxoline in vasculopathic syndromes. II. Peripheral rheographic studies of the lower extremities].
Rottini E; Martinelli M; Capitanucci P; De Gregorio M
Boll Soc Ital Biol Sper; 1967 Aug; 43(16):970-2. PubMed ID: 6073457
[No Abstract] [Full Text] [Related]
11. [Treatment of organic diseases of peripheral arteries with nicotinic acid derivatives].
Liszewska D; Lukasik E
Pol Tyg Lek; 1967 May; 22(21):794-6. PubMed ID: 6041002
[No Abstract] [Full Text] [Related]
12. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. I. Clinical results in various evolutive phases].
Zanelli G; Ferrero S; Patrone P
Minerva Cardioangiol; 1971 Nov; 19(11):605-15. PubMed ID: 5128422
[No Abstract] [Full Text] [Related]
13. [Rheographic study of the activity of some vasoactive drugs on peripheral arterial circulation].
Capitanucci P; Martinelli M; De Gregorio M
Minerva Cardioangiol; 1968 Nov; 16(11):1074-82. PubMed ID: 5707452
[No Abstract] [Full Text] [Related]
14. [Experiences with the treatment of peripheral vascular diseases with Xavin].
Brücknerová O
Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
[No Abstract] [Full Text] [Related]
15. [Experience with Complamin in peripheral circulation disorders].
Wittenburg H
Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
[No Abstract] [Full Text] [Related]
16. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
Buccellato C; Di Lorenzo GD
Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
[No Abstract] [Full Text] [Related]
17. [On the therapeutic activity of hemaseril in treatment of ischemic arteriopathies and phlebopathies].
Tattoni G; Bigazzi P; Gritta G
Clin Ter; 1974 Mar; 69(3):225-39. PubMed ID: 4846656
[No Abstract] [Full Text] [Related]
18. [Clinical and instrumental observations on the hemodynamic activity of a new drug: 7-(2-(3-pyridyl-methylamino)-ethyl)-theophylline nicotinate].
Jovino R; Renda A
Minerva Cardioangiol; 1971 Dec; 19(12):709-18. PubMed ID: 5129037
[No Abstract] [Full Text] [Related]
19. [Contribution to the study of internal temperatures in subjects with arterial diseases with obliterating evolution. I. Effects of sodium nicotinate, theophylline-ethylenediamine and theophylline nicotinate].
Blasi A; Licciardello M
Boll Soc Ital Cardiol; 1966; 11(4):1111-5. PubMed ID: 5992024
[No Abstract] [Full Text] [Related]
20. [The vasoactivogram in the treatment of peripheral arteriopathies].
Romeo S; Spinella G; Sciacchitanto D
Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
[No Abstract] [Full Text] [Related]
[Next] [New Search]
